Showing 22,361 results

Filters Content type: Editors' picks
HIV treatment for children & young people

New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet

Editor's pick
i-Base
16 November 2020
Government, leadership & policy

Three Immediate Ways the Fight Against HIV Is Likely to Change in the Biden-Harris Administration

Editor's pick
TheBodyPro
16 November 2020
Combatting stigma

Interactive TV series about HIV launched in Kyrgyzstan

Editor's pick
UNAIDS
16 November 2020
Diabetes

Bictegravir and Dolutegravir Tied to Metabolic Side Effects

Editor's pick
POZ
16 November 2020
Confidentiality, consent & medical ethics

New South Wales Government's Proposed Mandatory HIV Testing Condemned

Editor's pick
Star Observer
16 November 2020
HIV treatment for children & young people

ART reduces risk that children with HIV will die from TB

Editor's pick
Healio
16 November 2020
Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Improving HIV care

Escalate HIV Adherence Strategies Amid COVID-19

Editor's pick
Medscape (requires free registration)
16 November 2020
HIV treatment for children & young people

ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

Editor's pick
ViiV press release
13 November 2020
Weight gain & lipodystrophy

Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men

Editor's pick
Infectious Disease Advisor
12 November 2020
Coronavirus

COVID-19 antibody testing for HIV positive people in the UK: HIV organisations reverse previous exclusion

Editor's pick
i-Base
11 November 2020
Improving HIV care

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

Editor's pick
TheBodyPro
11 November 2020
People & personal stories

IAS names Birgit Poniatowski as IAS Executive Director

Editor's pick
International AIDS Society
11 November 2020
Clinical trials

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Editor's pick
FDA
10 November 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting PrEP

HIV prevention injection hailed as a “major breakthrough” for women

Editor's pick
Spotlight
10 November 2020
Drug policy & policing

Where the Biden Administration Will Stand on Drugs and Harm Reduction

Editor's pick
Filter
10 November 2020
Injectable & long-acting PrEP

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Editor's pick
ViiV press release
9 November 2020
Activism & civil society

The trans community organisers taking healthcare into their own hands

Editor's pick
i-D
6 November 2020
PrEP programmes & uptake

‘PrEP for Women Too’ Campaign Aims to Bring This Empowering HIV Prevention Tool to More Black and Latinx Women

Editor's pick
TheBodyPro
6 November 2020
Drug policy & policing

US voters put a major dent in the drug war — that's good

Editor's pick
The Hill
6 November 2020
Harm reduction

I opened the first safe consumption facility in Scotland to reduce disease and save people's lives

Editor's pick
MyPOV (video)
4 November 2020
Activism & civil society

Ten black HIV activists and influencers making an impact

Editor's pick
Terrence Higgins Trust
4 November 2020